MUSCAT : The Isotears pharmaceutical product registered and sold in Oman is not covered by circulating recall notices, the Ministry of Health said, clarifying that it is made by a different manufacturer.
The ministry’s Drug Safety Centre said a review of registration and import records showed that Isotears Plus ED and Clasgen, manufactured by Huons–Korea, had never been imported or supplied to the Sultanate.
The Isotears product available in the Omani market is manufactured by Amman Pharmaceutical Industries, a separate company from the manufacturer of the two products covered by the recall notices, the centre said.
Read More
- TAS Special Report: Al Khuwair roadworks turn daily commute into an ordeal
- Oman joins Gulf states in railway agreement to link six countries
- Oman’s Shura Council reviews call to regulate expatriate remittances
- Oman’s foreign minister, UN envoy discuss Yemen de-escalation and peace efforts
- Oman targets 30% medicine self-sufficiency within a decade, minister says
It urged consumers and patients who had obtained either of the recalled products from outside Oman or through online sales platforms to stop using them, regardless of the batch number.
Those affected should consult a doctor or pharmacist for advice and suitable treatment alternatives, it added.
The ministry said the clarification aimed to ensure the accuracy of information in circulation, protect public health and strengthen confidence in Oman’s pharmaceutical regulatory system.
For all the latest news from Oman and GCC, follow us on Twitter, Instagram and LinkedIn, like us on Facebook and subscribe to our YouTube page, which is updated daily.
